miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor. - Wikidata - wikimedia - TriplyDB

miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.

miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.

http://www.wikidata.org/entity/Q44077666

about

Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer MicroRNAs: Clinical Relevance in Colorectal Cancer Non-coding landscapes of colorectal cancer An update on microRNAs as colorectal cancer biomarkers: where are we and what's next?Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer.Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells.Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.Current approaches for predicting a lack of response to anti-EGFR therapy in KRAS wild-type patients Assay of lapatinib in murine models of cigarette smoke carcinogenesis.Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.LEF1 targeting EMT in prostate cancer invasion is mediated by miR-181a.miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.Infinity: An In-Silico Tool for Genome-Wide Prediction of Specific DNA Matrices in miRNA Genomic Loci.MicroRNA-181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib.Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer.MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer.Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.Genetic markers of recurrence in colorectal cancer.miR-181a involves in the hippocampus-dependent memory formation via targeting PRKAA1.Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma.Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancer.Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer.The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer.MicroRNA-561 inhibits gastric cancercell proliferation and invasion by downregulating c-Myc expression.MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review.Recent Advances in Understanding Cholangiocarcinoma.Altered microRNA expression patterns during the initiation and promotion stages of neonatal diethylstilbestrol-induced dysplasia/neoplasia in the hamster (Mesocricetus auratus) uterus.STAT1 Inhibits MiR-181a Expression to Suppress Colorectal Cancer Cell Proliferation Through PTEN/Akt.N-myc downstream-regulated gene 2 inhibits human cholangiocarcinoma progression and is regulated by leukemia inhibitory factor/MicroRNA-181c negative feedback pathway.miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway.MicroRNAs expression in normal and malignant colon tissues as biomarkers of colorectal cancer and in response to pomegranate extracts consumption: Critical issues to discern between modulatory effects and potential artefacts.

P2860

Q26772219-61532542-3FF4-4C1F-BB16-13E5349B02AA Q26775610-E0B2A1D3-7246-464B-8ED3-87C00D25AA4E Q26776039-E322AFB5-A512-4CBD-874C-A3509A7F86FB Q26778014-8FE75E52-D68F-4BB5-9C2B-5DBD7CCC1425 Q27024427-2B933026-08F3-4B2F-934C-A1FB15B30AF7 Q28249685-B54B97C1-C949-4434-99FF-632250394906 Q29248796-1492B6A4-363F-4CAA-A272-1D4B2083BF15 Q33599015-835FD4F0-6259-4DB1-9708-FA8E4919B460 Q33735050-B3D25E3E-EE18-49BB-8B8E-93CB8127751E Q33850074-BA2B6240-1574-4463-AD60-F80102A39A4C Q33861210-9E8A451B-2181-4360-A4FA-C808550FC7C9 Q34260243-7A433676-F917-41EB-A158-83F09BA0CC8A Q35125641-AB5C6826-1A8B-40A3-ABE0-75514A0725B7 Q35666448-7E91B1E5-5500-4AAE-BA59-5C6FA501E648 Q35739550-08BFAA6A-4358-4D65-957E-1D9FE8C11093 Q35990914-639E22A2-54C7-48C4-AF45-F9F63E5F2D71 Q36334277-DF5DAB72-B5D2-4EA2-ACEA-DC3FEDC14FFF Q36847230-8B1C8D5E-B0E8-4F4F-AFD0-CB066D79302B Q37644854-EA59CA91-DEA4-4F92-A67B-FEA07AEFDAB4 Q38222512-59EB4CFD-21B7-460C-B1A5-D014AB2B4F1A Q38247982-F918370A-FA27-4E25-B523-D84E7AA6BDB3 Q38545768-431C592B-598C-4528-8480-B8ADE6DA1F11 Q38555225-7009D551-938A-41D4-88CB-BCA13C26EE10 Q38565301-5E7A0D4E-EA74-4D88-8D17-48733E09FFEB Q38641480-6AAB21B2-EF26-4790-BE02-86D2AEC1B023 Q38732775-5926C0C1-9810-4867-877C-826F1F6DFF90 Q38805790-92B8AAA7-C5BA-49BE-8A89-BEEA8CC24542 Q38940586-5E3F086E-6815-4CF1-8575-873BB21E5AF1 Q39390383-AB46A9A8-7F05-4C37-BC0E-39462F7B9E95 Q39438832-E987DCA4-9E46-43C6-B04F-753B9647EE01 Q40129971-C1A519BC-868C-4ADB-A267-580ECB89FB27 Q40864983-1AE20464-56A0-44CF-83B6-2DD95553E627 Q41210209-4200525A-C051-4ACC-8CEB-3176D1827318 Q41660637-3D797F48-7177-46BE-825B-1758EF38E358 Q47165549-86DEBC8B-4FD6-4B60-9704-0BE419A0D656 Q47838011-3A17DB78-BAFD-4F45-9B80-638F76D07D08 Q48098812-B2188F27-F1B1-450E-9CB4-C98495835E31 Q51566647-306787CC-5331-405B-A83B-9F3DF0999551 Q52683993-9289214A-91EA-4B1D-A68E-6206A56BD39A Q53456657-D179489C-55BC-4B33-8C63-1404D930D331

P2860

miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.

http://www.wikidata.org/entity/Q44077666

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

miR-181a is associated with po ...... r treated with EGFR inhibitor.

@en

miR-181a is associated with po ...... r treated with EGFR inhibitor.

@nl

type

label

miR-181a is associated with po ...... r treated with EGFR inhibitor.

@en

miR-181a is associated with po ...... r treated with EGFR inhibitor.

@nl

prefLabel

miR-181a is associated with po ...... r treated with EGFR inhibitor.

@en

miR-181a is associated with po ...... r treated with EGFR inhibitor.

@nl

P1433

Q44077666-D7F6C7D7-9023-487F-8ED6-EF04258628DA

P1476

Q44077666-04F16EEF-D7B0-48A9-97A6-A7447825A96E

P2093

Q44077666-185D54C6-3BC1-4844-ACAA-CC1407E1E095

Q44077666-3C9F3CF8-C469-47BB-8DC9-6AEBBA873415

Q44077666-462E3AB9-E533-4431-8386-19704F70B0AF

Q44077666-656A184B-5ACD-4665-8871-CF45242B7BE4

Q44077666-8E105EAA-AD97-4FC4-A7F3-D6FF259ABB82

Q44077666-915FDAD9-9B8C-473E-835E-874C8A9C5568

Q44077666-927A448E-27E3-49A9-AD42-40EF31AD03B6

P2860

Q44077666-0C6F5994-1972-41A8-A1E7-AADE1737A9D4

Q44077666-1713CAAA-1010-4DAF-AC44-E0F5E36248BD

Q44077666-1BFC7E56-6DC2-4CFC-8CFF-0B3CF4767C03

Q44077666-287F378C-865F-440C-BCD7-E2D4C3B2A543

Q44077666-2D3514FA-8CD7-42EA-958C-1FF641B1BEF3

Q44077666-3004B50A-244C-40E8-BC10-B79F67BF2448

Q44077666-3320173A-028E-4762-A7C0-B15731C48CF1

Q44077666-372B5A26-8E5D-48E9-A1EF-1433A7B1041B

Q44077666-4EB77FEF-C056-43EA-B216-2D8320D666FA

Q44077666-5110B0D1-306B-4D34-9FEA-0FB362FAC385

P304

Q44077666-73FA46FC-63EA-4E50-9837-BA49264788C3

P31

Q44077666-611ECB66-AF0E-4B87-BF22-88D2D46048CE

P356

Q44077666-073F9C0D-65A7-4801-9D4A-C95CEB369E5E

P407

Q44077666-4DF32E49-F944-474A-B525-097C0CC056C4

P433

Q44077666-52FE112E-503B-4594-917E-BBD04130B37D

P478

Q44077666-0DD52808-2115-4733-9C8A-61F6F824B281

P50

Q44077666-673D592E-0F05-4586-8EEC-78D53A4E86C8

Q44077666-C0A2DF8F-3E97-43DE-8D88-A4698A31EC74

P577

Q44077666-21800BC4-E5DF-4AD5-AA5A-0A219875B2DD

P5875

Q44077666-30FBD9C5-4EF5-45F4-8409-80E239DE8AFE

P698

Q44077666-E0521112-22A9-47B8-BEE4-5C34DC153312

P921

Q44077666-5B8845BF-5A66-46C4-B283-A986336358F9

Q44077666-8F0C026A-6F15-444D-9169-4F887A3B8D7A

P356

JCLINPATH-2013-201904

P1433

Journal of Clinical Pathology

P1476

miR-181a is associated with po ...... r treated with EGFR inhibitor.

@en

P2093

Anna Lena Ress

http://www.w3.org/2001/XMLSchema#string

Armin Gerger

http://www.w3.org/2001/XMLSchema#string

Elke Winter

http://www.w3.org/2001/XMLSchema#string

Hellmut Samonigg

http://www.w3.org/2001/XMLSchema#string

Martin Pichler

http://www.w3.org/2001/XMLSchema#string

Sigurd Lax

http://www.w3.org/2001/XMLSchema#string

Thomas Bauernhofer

http://www.w3.org/2001/XMLSchema#string

P2860

Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma

A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

MicroRNAs modulate hematopoietic lineage differentiation

MicroRNA signatures in human cancers

Analyzing real-time PCR data by the comparative C(T) method

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181

P304

198-203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JCLINPATH-2013-201904

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P50

Tobias Kiesslich

P577

2013-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257464188

http://www.w3.org/2001/XMLSchema#string

P698

24098024

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer